BICYCLE THERAPEUTICS PLC's ticker is BCYC and the CUSIP is 088786108. A total of 101 filers reported holding BICYCLE THERAPEUTICS PLC in Q4 2021. The put-call ratio across all filers is 0.53 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,300,600 | -44.0% | 910,930 | -28.9% | 0.01% | -40.0% |
| Q2 2023 | $32,696,892 | +4.3% | 1,281,324 | -13.1% | 0.02% | -4.8% |
| Q1 2023 | $31,363,631 | -29.5% | 1,474,378 | -1.9% | 0.02% | -34.4% |
| Q4 2022 | $44,483,761 | +13.6% | 1,503,447 | -55.3% | 0.03% | +10.3% |
| Q3 2022 | $39,156,117 | +69.8% | 3,361,698 | +144.6% | 0.03% | +81.2% |
| Q2 2022 | $23,066,000 | -69.0% | 1,374,489 | -18.8% | 0.02% | -55.6% |
| Q1 2022 | $74,297,000 | -28.0% | 1,692,774 | -0.2% | 0.04% | -16.3% |
| Q4 2021 | $103,177,000 | +42.2% | 1,695,409 | -2.7% | 0.04% | +34.4% |
| Q3 2021 | $72,557,000 | +29.1% | 1,743,005 | -5.8% | 0.03% | +33.3% |
| Q2 2021 | $56,202,000 | +11.0% | 1,849,720 | +9.2% | 0.02% | +4.3% |
| Q1 2021 | $50,654,000 | – | 1,693,658 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradigm Biocapital Advisors LP | 3,642,307 | $73,173,948 | 4.96% |
| Sio Capital Management, LLC | 796,933 | $16,010,384 | 4.96% |
| First Light Asset Management, LLC | 2,070,853 | $41,603,437 | 3.95% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 1,281,820 | $25,751,764 | 3.60% |
| Deep Track Capital, LP | 3,490,506 | $70,124,266 | 2.71% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,010,976 | $20,310,508 | 1.10% |
| HighVista Strategies LLC | 92,434 | $1,856,999 | 0.86% |
| BRAIDWELL LP | 1,289,872 | $25,913,528 | 0.82% |
| DAFNA Capital Management LLC | 122,200 | $2,454,998 | 0.76% |
| Soleus Capital Management, L.P. | 391,800 | $7,871,262 | 0.73% |